|
Post by JHam on Jun 21, 2015 17:44:10 GMT
I just read in a few different places that Fiorino recently said they have enrolled 31 patients so far. So I guess that is old (but good) news.
|
|
|
Post by JHam on Jun 22, 2015 10:46:50 GMT
|
|
|
Post by JHam on Jun 29, 2015 12:47:30 GMT
BCLI also added to the Russell index (Microcap) today.
|
|
|
Post by Yelk on Jul 17, 2015 3:47:17 GMT
Near all time lows here... monitoring. If any dip at all tomorrow will start in fresh 1/5 style. Not currently in. Article popped up today forgot about this one.
|
|
|
Post by JHam on Jul 17, 2015 7:05:43 GMT
Near all time lows here... monitoring. If any dip at all tomorrow will start in fresh 1/5 style. Not currently in. Article popped up today forgot about this one. This one is back on my radar. As you said it has been trickling down for a while now and they have several major milestones coming up. Here is a look at their updated list of milestones from the Cantor Fitzgerald presentation:
|
|
|
Post by JHam on Jul 21, 2015 11:04:40 GMT
|
|
|
Post by dayanand33 on Jul 21, 2015 14:07:13 GMT
"The novel concept of injecting the stem cells directly into the spinal fluid is aimed at getting the cells to circulate to the various damaged areas of the central nervous system." I may be missing something but I thought BCLI did not inject cells directly into spinal fluids in case of ALS.
|
|
|
Post by JHam on Jul 21, 2015 14:22:30 GMT
"The novel concept of injecting the stem cells directly into the spinal fluid is aimed at getting the cells to circulate to the various damaged areas of the central nervous system." I may be missing something but I thought BCLI did not inject cells directly into spinal fluids in case of ALS. They direct them into the arm and into the spine. Trial protocol from clinicaltrials.gov: Detailed Description:
The MSC-NTF cell therapy (NurOwn™) is based on transplantation of autologous bone marrow derived mesenchymal stromal cells (MSC), which are enriched from the patients' own bone marrow, propagated ex vivo and induced to secrete NTFs. The autologous MSC-NTF cells are back-transplanted into the ALS patient into the sites of damage, the spinal cord and the muscles.
|
|
|
Post by JHam on Jul 24, 2015 12:11:43 GMT
I don't know if any of you noticed this in the proxy, but they are proposing to reduce the number of a/s. Don't know why they didn't do this when they did the r/s. I know this bothered a lot of people (me included) so good to see if this passes:
2. To approve an amendment to the Company’s Certificate of Incorporation to reduce the number of authorized shares of our common stock from 800,000,000 to 100,000,000;
|
|
|
Post by actcfan on Aug 6, 2015 15:40:22 GMT
Any news out to cause the decline? I don't see anything.
|
|
|
Post by jckrdu on Aug 6, 2015 15:56:28 GMT
Any news out to cause the decline? I don't see anything. Biotech indexes both down big today... 4% - 5% (IBB and XBI). Could just be moving with the sector.
|
|
|
Post by selluwud on Aug 6, 2015 15:57:34 GMT
Any news out to cause the decline? I don't see anything. Did a patient expire? I'm sure with the patient profile used in the trials that it wouldn't be unusual, but the market would not like it. Just making a wild ass guess for lack of any other explanation.
|
|
|
Post by RLC on Aug 6, 2015 16:14:21 GMT
Any news out to cause the decline? I don't see anything. They report Q2 earnings a week from today. Maybe there's some negative whispers going around about what will or won't be discussed on that call... ? Really not sure. The market has been brutal lately!
|
|
|
Post by JHam on Aug 6, 2015 18:24:48 GMT
Any news out to cause the decline? I don't see anything. They report Q2 earnings a week from today. Maybe there's some negative whispers going around about what will or won't be discussed on that call... ? Really not sure. The market has been brutal lately! Yeah maybe. The entire biotech sector is getting creamed today. Pretty crazy.
|
|
|
Post by dayanand33 on Aug 7, 2015 15:10:49 GMT
They report Q2 earnings a week from today. Maybe there's some negative whispers going around about what will or won't be discussed on that call... ? Really not sure. The market has been brutal lately! Yeah maybe. The entire biotech sector is getting creamed today. Pretty crazy. Near 52 week low. Couldn't resist. Opened a small position. Also picked up some OCAT and CUR. Everybody is getting beaten up. Feel safer to pickup shares when the sector is getting beaten up.
|
|
|
Post by JHam on Aug 10, 2015 14:19:39 GMT
Yeah maybe. The entire biotech sector is getting creamed today. Pretty crazy. Near 52 week low. Couldn't resist. Opened a small position. Also picked up some OCAT and CUR. Everybody is getting beaten up. Feel safer to pickup shares when the sector is getting beaten up. Totally agree. I really wish I had some ammo to take advantage of the last couple days. I am really itching to get back in this one especially when it's under $3 still. Can anyone lend me some money?
|
|
|
Post by Yelk on Aug 11, 2015 1:57:39 GMT
Is this the opportunity to get long here or is it going to $1 lol. Crazy.. Seems low risk to me at these levels with 2016 catalyst. Tempted to start in 1/10 size.
|
|
|
Post by JHam on Aug 11, 2015 10:12:38 GMT
Is this the opportunity to get long here or is it going to $1 lol. Crazy.. Seems low risk to me at these levels with 2016 catalyst. Tempted to start in 1/10 size. It is always impossible to answer whether or not it is going to lower. $1 seems like a stretch. I would be stunned to see it go lower than $2. I agree that the risk/reward ratio is very good at these levels and I would feel very comfortable personally adding right now if I had some extra dry powder. Loads of catalysts coming up and we already saw once how fast this one can move on good news (or good news anticipation) with such a low float. If if it stays below $3 today I might do some pruning of my other holdings so that I can open a small position.
|
|
|
Post by JHam on Aug 30, 2015 3:29:07 GMT
|
|
|
Post by dayanand33 on Sept 28, 2015 17:02:45 GMT
Bought some shares at $2.31 We are at a 52 week low. The volume is just about twice the average daily volume but the stock has tanked about 17%. I think the drop is too step for such a low volume. The drop is most likely related to CEO's departure. Plan to keep adding more if this one falls further.
|
|